CIK 0002104204 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alamar Biosciences, Inc.
Sign in to watch- Ticker
- ALMR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364899036
- Phone
- 510-626-9888
- Business address
- 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,561,405
- in 7 filings
Net −$44,561,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-16 | Luo Yuling Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +341,191 | 341,191 | ||
| 2026-04-16 | White Timothy Ogden President | Grant or award · Stock Option (Right to Buy) | +163,358 | 163,358 | ||
| 2026-04-16 | McAnear Justin J. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +163,358 | 163,358 | ||
| 2026-04-16 | Naclerio Nicholas Director | Grant or award · Stock Option (Right to Buy) | +25,599 | 25,599 |
Page 13 of 13 · 244 trades